Udo Rudloff, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Udo Rudloff, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:03 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04327986 · Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas CancerNational Cancer Institute (NCI) · terminated · Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic Neoplasms · principal investigator
- Ph1NCT04222413 · Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsNational Cancer Institute (NCI) · recruiting · Advanced Solid Tumors, Metastatic Pancreatic Cancer, Pediatric Solid Tumor · principal investigator
- Ph1/Ph2NCT03451773 · M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the PancreasNational Cancer Institute (NCI) · terminated · Cancer of Pancreas, Pancreas Cancer, Pancreatic Adenocarcinoma · principal investigator
- Ph1NCT01437007 · TKM 080301 for Primary or Secondary Liver CancerNational Cancer Institute (NCI) · completed · Colorectal Cancer With Hepatic Metastases, Pancreas Cancer With Hepatic Metastase, Gastric Cancer With Hepatic Metastase · principal investigator
- Ph1NCT01294358 · Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialNational Cancer Institute (NCI) · completed · Histologically or Cytologically Confirmed Pancreatic Ca, Unresectable or Borderline Resectable Pancreatic Ca · principal investigator
- Ph2NCT01264081 · Lapatinib in Stage IV Melanoma With ERBB4 MutationsNational Cancer Institute (NCI) · terminated · Malignant Melanoma · principal investigator
- Ph3NCT00941655 · Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA TrialNational Cancer Institute (NCI) · completed · Gastric Cancer · principal investigator
- N/ANCT00923052 · The Natural History of Solid Organ Cancer Stem Cells (SOCSC)National Cancer Institute (NCI) · terminated · Hepatic Cancer, Pancreatic Ductal Cancer, Colorectal Cancer · principal investigator
- N/ANCT00100321 · Surgery for Pancreatic Tumors and Collection of Tumor Tissue for StudyNational Cancer Institute (NCI) · terminated · Pancreatic Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.